Products for Research Use Only
RegisterLogin

Emavusertib (tosylate)

CAT: 0804-HY-135317CSize: 1 EachDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-135317CSize:1 Each
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Emavusertib tosylate (CA-4948 tosylate) is the tosylate salt form of Emavusertib. Emavusertib tosylate is an orally active inhibitor for IRAK4 (IC50=57 nM) and FLT3. Emavusertib tosylate inhibits NF-κB and MyD88 signaling pathways, reduces the generation of pro-inflammatory cytokines like IL-6 and IL-10, thereby exhibiting anti-inflammatory and anti-proliferative activities against cancer cells, leading to cell apoptosis. Emavusertib tosylate exhibits antitumor activity in mouse model[1][2][3].
CAS Number
2376399-41-4
Product Name Alternative
CA-4948 (tosylate)
UNSPSC
12352005
Target
Apoptosis; FLT3; IRAK; MyD88; NF-κB
Related Pathways
Apoptosis; Immunology/Inflammation; NF-κB; Protein Tyrosine Kinase/RTK
Field of Research
Cancer; Inflammation/Immunology
Smiles
O=S(O)(C1=CC=C(C=C1)C)=O.O=C(C2=COC(C3=CC=NC(C)=C3)=N2)NC4=C(N5CC[C@H](C5)O)N=C6C(OC(N7CCOCC7)=N6)=C4
Molecular Formula
C31H33N7O8S
Molecular Weight
663.70
References & Citations
[1]Wiese MD, et al. Investigational IRAK-4 inhibitors for the treatment of rheumatoid arthritis. Expert Opin Investig Drugs. 2020 Apr 17:1-8.|[2]Guidetti F, et al. Targeting IRAK4 with Emavusertib in Lymphoma Models with Secondary Resistance to PI3K and BTK Inhibitors. J Clin Med. 2023 Jan 4;12 (2) :399. |[3]Parrondo RD, et al. IRAK-4 inhibition: emavusertib for the treatment of lymphoid and myeloid malignancies. Front Immunol. 2023 Oct 26;14:1239082.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
Phase 2

Related Products

CatalogName
HY-135317-01Emavusertib
HY-135317EEmavusertib (maleate)
HY-135317DEmavusertib (mesylate)
HY-135317BEmavusertib (hydrochloride)
HY-135317FEmavusertib (phosphate)
HY-19733-01Lumateperone (tosylate)
HY-18263C-01Elubrixin (tosylate)
HY-100754C-01Ritlecitinib (tosylate)
HY-108477-01TMPyP4 tosylate
HY-112802A-01Ubavitinib (tosylate)

Alternative Products

CatalogName
GTR19241774-01Emavusertib Tosylate
462493Emavusertib
A22489-50Emavusertib 50mg
A22489-2Emavusertib 2mg
GTR19242294-01Emavusertib Maleate
T202763-01Emavusertib Mesylate
T86366-01Emavusertib hydrochloride
A22489-25Emavusertib 25mg
A22489-1Emavusertib 1mg
GTR19241701-01Emavusertib Phosphate

Popular Products